AstraZeneca PLC (NASDAQ:AZN) is considered one of the best UK stocks to buy right now, with a Buy rating and $97 price target from Goldman Sachs analyst Rajan Sharma. The company’s growth potential in innovative drugs, particularly in cardiovascular and oncology segments, positions it for sustained revenue growth.

Strategic acquisitions and partnerships have enhanced AstraZeneca’s research capabilities and product offerings, giving the company a competitive edge in the pharmaceutical industry. The company explores, develops, manufactures, and commercializes prescription medicines, supplying products to specialty and primary care physicians through local representative offices and distributors.

While AstraZeneca (AZN) shows strong investment potential, certain AI stocks may offer greater upside potential with less downside risk. Investors seeking undervalued AI stocks can explore opportunities that stand to benefit from Trump-era tariffs and onshoring trends. The article also highlights other stock investment opportunities for consideration.

Read more at Yahoo Finance: Goldman Sachs Remains Bullish on AstraZeneca (AZN)